Table 1.
Association between clinicopathological characteristics and subtype.
| Clinicopathological Parameter | Subtype A | Subtype B | p-Value |
|---|---|---|---|
| Gender | 0.20 | ||
| F | 25 | 13 | |
| M | 32 | 8 | |
| Mutation MEN1/ATRX/DAXX | 7.6E-06 | ||
| No | 10 | 13 | |
| Yes | 38 | 2 | |
| WHO Grade | 0.66 | ||
| G1 | 27 | 12 | |
| G2 | 22 | 8 | |
| G3 | 3 | 0 | |
| Functionality | 0.011 | ||
| Gastrinoma | 1 | 1 | |
| Glucagonoma | 1 | 0 | |
| Insulinoma | 2 | 6 | |
| Non-functional | 46 | 13 | |
| VIPoma | 2 | 0 | |
| LVI | 0.059 | ||
| No | 14 | 8 | |
| Yes | 31 | 5 | |
| Distant metastasis | 0.022 | ||
| No | 32 | 18 | |
| Yes | 21 | 2 | |
| Recurrence | 5.9E-04 | ||
| No | 14 | 16 | |
| Yes | 13 | 0 | |
| Age | 57.1 (±12.1) | 53.1 (±15.0) | 0.29 |
| Tumor size | 4.4 (±2.6) | 3.77 (±3.2) | 0.18 |
The counts are shown for categorical variables and the mean (±standard deviation) for continuous variables. Significant p-values (≤ 0.05) are indicated in bold. (LVI, lymphovascular invasion).